Andreas H. Wagner

4.4k total citations
97 papers, 2.9k citations indexed

About

Andreas H. Wagner is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Andreas H. Wagner has authored 97 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 26 papers in Molecular Biology and 21 papers in Surgery. Recurrent topics in Andreas H. Wagner's work include Atherosclerosis and Cardiovascular Diseases (13 papers), Cell Adhesion Molecules Research (13 papers) and Nitric Oxide and Endothelin Effects (12 papers). Andreas H. Wagner is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (13 papers), Cell Adhesion Molecules Research (13 papers) and Nitric Oxide and Endothelin Effects (12 papers). Andreas H. Wagner collaborates with scholars based in Germany, United States and Netherlands. Andreas H. Wagner's co-authors include Markus Hecker, Ingo Just, Thomas Köhler, Marco Cattaruzza, Marco R. Schroeter, Matthias Gebauer, Bernward Lauer, Marc‐Alexander Ohlow, Thomas Korff and F. Mohr and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Andreas H. Wagner

95 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas H. Wagner Germany 29 766 708 662 564 531 97 2.9k
Dale J. Hamilton United States 22 779 1.0× 577 0.8× 412 0.6× 421 0.7× 385 0.7× 64 2.4k
Marie‐Luise Brennan United States 17 758 1.0× 1.5k 2.1× 661 1.0× 562 1.0× 837 1.6× 28 3.4k
Qingwei Zhao China 31 1.4k 1.8× 671 0.9× 565 0.9× 493 0.9× 393 0.7× 98 3.5k
Assunta Pandolfi Italy 32 1.4k 1.9× 565 0.8× 491 0.7× 366 0.6× 677 1.3× 109 3.6k
Geoff H. Werstuck Canada 33 1.3k 1.7× 571 0.8× 690 1.0× 307 0.5× 500 0.9× 81 3.9k
Concepción Peiró Spain 34 1.2k 1.6× 517 0.7× 736 1.1× 758 1.3× 957 1.8× 92 4.3k
Weibin Shi United States 26 1.1k 1.5× 1.0k 1.5× 561 0.8× 388 0.7× 471 0.9× 110 3.1k
Lillemor Mattsson Hultén Sweden 28 1.1k 1.5× 942 1.3× 920 1.4× 504 0.9× 410 0.8× 74 3.2k
Yasuko Iwakiri United States 40 1.3k 1.7× 442 0.6× 1.3k 2.0× 348 0.6× 839 1.6× 87 5.2k
Ashley Hale United Kingdom 27 930 1.2× 437 0.6× 274 0.4× 404 0.7× 638 1.2× 48 2.3k

Countries citing papers authored by Andreas H. Wagner

Since Specialization
Citations

This map shows the geographic impact of Andreas H. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas H. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas H. Wagner more than expected).

Fields of papers citing papers by Andreas H. Wagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas H. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas H. Wagner. The network helps show where Andreas H. Wagner may publish in the future.

Co-authorship network of co-authors of Andreas H. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas H. Wagner. A scholar is included among the top collaborators of Andreas H. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas H. Wagner. Andreas H. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagner, Andreas H., Michal Itan, Israel Zan‐Bar, et al.. (2025). Distinct Roles for Thymic Stromal Lymphopoietin ( TSLP ) and IL ‐33 in Experimental Eosinophilic Esophagitis. Allergy. 80(11). 3095–3107.
2.
Goo, Young‐Hwa, Sushant Bangru, Pradip Saha, et al.. (2024). Lipid droplet-associated hydrolase mobilizes stores of liver X receptor sterol ligands and protects against atherosclerosis. Nature Communications. 15(1). 6540–6540. 3 indexed citations
3.
4.
5.
Mohr, F., Anca Remes, Rawa Arif, et al.. (2022). Short-term rapamycin treatment increases life span and attenuates aortic aneurysm in a murine model of Marfan-Syndrome. Biochemical Pharmacology. 205. 115280–115280. 12 indexed citations
6.
Fleming, Thomas, Dagmar Schumacher, F. Mohr, et al.. (2019). Methylglyoxal evokes acute Ca2+ transients in distinct cell types and increases agonist-evoked Ca2+ entry in endothelial cells via CRAC channels. Cell Calcium. 78. 66–75. 11 indexed citations
7.
Arnold, Caroline, et al.. (2018). Glycyrrhetinic Acid Antagonizes Pressure-Induced Venous Remodeling in Mice. Frontiers in Physiology. 9. 320–320. 2 indexed citations
8.
Popa, Miruna, Julia Elrod, Su Hwan Kim, et al.. (2018). Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell–platelet–monocyte interaction. Proceedings of the National Academy of Sciences. 115(24). E5556–E5565. 36 indexed citations
9.
Seppelt, Philipp, Simon Schwill, Alexander Weymann, et al.. (2016). Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene Therapy. PLoS ONE. 11(2). e0148012–e0148012. 12 indexed citations
10.
Ghosh, Subhajit, Branislav Kollár, Sahana Suresh Babu, et al.. (2015). Loss of the Mechanotransducer Zyxin Promotes a Synthetic Phenotype of Vascular Smooth Muscle Cells. Journal of the American Heart Association. 4(6). e001712–e001712. 28 indexed citations
11.
Adolph, Oliver, Julia Elrod, Miruna Popa, et al.. (2015). Mechanism and functional impact of CD40 ligand-induced von Willebrand factor release from endothelial cells. Thrombosis and Haemostasis. 113(5). 1095–1108. 17 indexed citations
12.
Peters, Verena, Albert Amberger, Thomas Fleming, et al.. (2015). Carnosine metabolism in diabetes is altered by reactive metabolites. Amino Acids. 47(11). 2367–2376. 31 indexed citations
13.
Wagner, Andreas H., Anke Hildebrandt, Sebastian Baumgarten, et al.. (2011). Tyrosine nitration limits stretch-induced CD40 expression and disconnects CD40 signaling in human endothelial cells. Blood. 118(13). 3734–3742. 16 indexed citations
14.
Stojanović, Tomislav, Andreas H. Wagner, Shijun Wang, et al.. (2009). STAT-1 decoy oligodeoxynucleotide inhibition of acute rejection in mouse heart transplants. Basic Research in Cardiology. 104(6). 719–729. 15 indexed citations
15.
Korn, Hubertus von, Marc‐Alexander Ohlow, Jiangtao Yu, et al.. (2008). A New Vascular Closure Device for the Transradial Approach: The D Stat Radial System. Journal of Interventional Cardiology. 21(4). 337–341. 6 indexed citations
16.
Levak‐Frank, Sanja, et al.. (2003). Intercellular signalling within vascular cells under high D-glucose involves free radical-triggered tyrosine kinase activation. Diabetologia. 46(6). 773–783. 25 indexed citations
17.
Schweyer, Stefan, Afsaneh Soruri, J. H. Peters, et al.. (2003). Malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ. British Journal of Cancer. 89(5). 915–921. 10 indexed citations
18.
Wagner, Andreas H., et al.. (2002). Atorvastatin inhibition of cytokine‐inducible nitric oxide synthase expression in native endothelial cellsin situ. British Journal of Pharmacology. 136(1). 143–149. 84 indexed citations
19.
Buchwald, Arnd B., et al.. (2002). Decoy oligodeoxynucleotide againstactivator protein-1 reducesneointimal proliferation after coronaryangioplasty in hypercholesterolemic minipigs. Journal of the American College of Cardiology. 39(4). 732–738. 31 indexed citations
20.
Hecker, Markus, Marco Cattaruzza, & Andreas H. Wagner. (1999). Regulation of Inducible Nitric Oxide Synthase Gene Expression in Vascular Smooth Muscle Cells. General Pharmacology The Vascular System. 32(1). 9–16. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale J. Hamilton Breakdown of academic impact, for papers by Marie‐Luise Brennan Breakdown of academic impact, for papers by Qingwei Zhao Breakdown of academic impact, for papers by Assunta Pandolfi Breakdown of academic impact, for papers by Geoff H. Werstuck Breakdown of academic impact, for papers by Concepción Peiró Breakdown of academic impact, for papers by Weibin Shi Breakdown of academic impact, for papers by Lillemor Mattsson Hultén Breakdown of academic impact, for papers by Yasuko Iwakiri Breakdown of academic impact, for papers by Ashley Hale
Rankless by CCL
2026